双响炮:两知名药企同日官宣超27亿美元全球授权

蒲公英Ouryao
Mar 05

转自:企业公告 编辑:水晶2026年3月4日,中国生物医药行业迎来“双响炮”——德琪医药与中国生物制药同日宣布达成两项重磅全球独家授权交易,总潜在交易金额合计超过27亿美元。这不仅彰显了本土创新药企的研发实力,也标志着中国原研药物加速走向全球市场的步伐进一步加快。中国生物制药×赛诺菲:15.3亿美元押注全球首创JAK/ROCK双靶点抑制剂中国生物制药与全球制药巨头赛诺菲(Sanofi)达成关于罗伐...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10